Graft vs autoimmunity following allogeneic non-myeloablative blood stem cell transplantation in a patient with chronic myelogenous leukemia and severe systemic psoriasis and psoriatic polyarthritis

Karussis, 1995, Chronic-relapsing experimental autoimmune encephalomyelitis (CR-EAE), J Neuroimmunol, 39, 201, 10.1016/0165-5728(92)90254-I Karussis, 1992, Prevention of experimental autoimmune encephalomyelitis and induction of tolerance with acute immunosuppression followed by syngeneic bone marrow transplantation, J Immunol, 148, 1693, 10.4049/jimmunol.148.6.1693 Karussis, 1993, Prevention and reversal of adoptively transferred chronic-relapsing experimental autoimmune encephalomyelitis (CR-EAE) with a single high dose cytoreductive treatment followed by syngeneic bone marrow transplantation, J Clin Invest, 92, 765, 10.1172/JCI116648 Slavin, 1993, Treatment of life threatening autoimmune diseases with myeloablative doses of immunosuppressive agents and autologous bone marrow transplantation—Rationale and experimental background, Bone Marrow Transplant, 12, 85 Van Bekkum, 1993, DW Review BMT in experimental autoimmune diseases, Bone Marrow Transplant, 11, 183 Ikehara, 1996, The prospects for BMT-from mouse to human Moscovitch, 1983, Regulation of the immune response in experimental models of autoimmune disorders. 1. Immunocompetence and transplantation tolerance in (NZB × NZW)F1 hybrid mice immunosuppressed with total lymphoid irradiation and in reconstituted bone marrow chimeras, J Clin Lab Immunol, 4, 185 Slavin, 1979, Successful treatment of autoimmune disease in (NZB/NZW)F1 female mice by using fractionated total lymphoid irradiation, Proc Natl Acad Sci USA, 76, 5274, 10.1073/pnas.76.10.5274 Moscovitch, 1983, Successful treatment of autoimmune manifestations in MRL/1 and MRL/n mice using total lymphoid irradiation (TLI), Exp Molec Pathol, 38, 33, 10.1016/0014-4800(83)90096-5 Slavin, 1993, Treatment of life threatening autoimmune diseases with myeloablative doses of immunosuppressive agents and autologous bone marrow transplantation—Rationale and experimental background, Bone Marrow Transplant, 2, 85 Kappler, 1988, Self-tolerance eliminates T cells specific for Mis-modified products of the major histocompatibility complex, Nature, 332, 35, 10.1038/332035a0 Morecki, 1987, Alloantigen persistence in induction and maintenance of transplantation tolerance, J Exp Med, 165, 1468, 10.1084/jem.165.6.1468 Slavin, 1976, Long-term survival of skin allografts in mice treated with fractionated total lymphoid irradiation, Science, 193, 1252, 10.1126/science.785599 Slavin, 1987, Total lymphoid irradiation (TLI), Immunol Today, 8, 88, 10.1016/0167-5699(87)90852-8 Slavin, 1998, Non-myeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and non-malignant hematologic diseases, Blood, 91, 756, 10.1182/blood.V91.3.756 Slavin, 1996, Allogeneic cell therapy with donor peripheral blood cells and recombinant human interleukin-2 to treat leukemia relapse post allogeneic bone marrow transplantation, Blood, 87, 2195, 10.1182/blood.V87.6.2195.bloodjournal8762195 Kolb, 1995, Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients, Blood, 86, 2041, 10.1182/blood.V86.5.2041.bloodjournal8652041 Collins, 1997, Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation, J Clin Oncol, 15, 433, 10.1200/JCO.1997.15.2.433 Aker, 1998, Donor lymphocyte infusions to displace residual host hematopoietic cells after allogeneic BMT for beta thalassemia major, J of Pediatric Hematology/Oncology, 20, 145, 10.1097/00043426-199803000-00011 Fassas, 1997, Peripheral blood stem cell transplantation in the treatment of progressive multiple sclerosis, Bone Marrow Transplant, 20, 631, 10.1038/sj.bmt.1700944 Pugatsch, 1996, Improved single-step PCR assay for sex identification post-allogeneic sex-mismatched BMT, Bone Marrow Transplantation, 17, 273 Marmont, 1997, Stem cell transplantation for severe autoimmune disorders, with special reference to rheumatic diseases, J Rheumatol, 24, 1 Giralt, 1997, Engraftment of allogeneic hematopoietic progenitor cells with purine analog-containing chemotherapy, Blood, 89, 4531, 10.1182/blood.V89.12.4531 Naparstek, 1995, T-cell-depleted allogeneic bone marrow transplantation for acute leukaemia using Campath-1 antibodies and post-transplant administration of donor's peripheral blood lymphocytes for prevention of relapse, Brit J Haematol, 89, 506, 10.1111/j.1365-2141.1995.tb08356.x Odom, 1978, Remission of relapsed leukaemia during a graft-versus-host reaction. A “graft-versus-leukaemia reaction” in man?, Lancet, 2, 537, 10.1016/S0140-6736(78)92879-9 Bacigalupo, 1991, Increased risk of leukemia relapse with high-dose cyclosporine A after allogeneic marrow transplantation for acute leukemia, Blood, 77, 1423, 10.1182/blood.V77.7.1423.1423 Ben-Yosef, 1996, Graft vs tumor and graft vs leukemia in patient with concurrent breast cancer and acute myelocytic leukemia, Lancet, 348, 1242, 10.1016/S0140-6736(05)65517-1 Morecki, 1997, Induction of graft vs tumor effect in a murine model of mammary adenocarcinoma, Int J Cancer, 71, 59, 10.1002/(SICI)1097-0215(19970328)71:1<59::AID-IJC11>3.0.CO;2-4 Slavin, 1978, Transplantation of allogeneic bone marrow without graft vs host disease using total lymphoid irradiation, J Exp Med, 47, 963, 10.1084/jem.147.4.963 Reisner, 1995, Bone marrow transplantation across HLA barriers by increasing the number of transplanted cells, Immunol Today, 16, 437, 10.1016/0167-5699(95)80021-2 Tyndall, 1997, Blood and marrow stem cell transplants in autoimmune disease (A consensus report), Brit J Rheumatology, 36, 390, 10.1093/rheumatology/36.3.390 Bonini, 1997, HSV-TK gene transfer into donor lymphocytes for control of allogeneic graft versus leukemia, Science, 276, 1719, 10.1126/science.276.5319.1719